Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Deficit)
Beginning balances (in shares) at Dec. 31, 2020   57,151,000    
Beginning balances at Dec. 31, 2020 $ 316,997 $ 57 $ 319,582 $ (2,642)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon warrant exercise (in shares)   40,000    
Common stock issued upon warrant exercise 111   111  
Common stock issued upon cashless warrant exercise (in shares)   535,000    
Common stock issued upon cashless warrant exercise 0 $ 1 (1)  
Common stock issued upon exercise of options (in shares)   1,000    
Common stock issued upon exercise of options 2   2  
Common stock issued upon cashless exercise of options (in shares)   5,000    
Common stock issued upon cashless exercise of options 0      
Common stock issued in connection with business combinations (in shares)   548,000    
Common stock issued in connection with business combination 29,249   29,249  
Common stock issued for assets (in shares)   300,000    
Common stock issued for assets 0      
Common stock issued for services (in shares)   (90,000)    
Common stock issued for services 0      
Common stock issued for share based compensation (in shares)   96,000    
Common stock issued for share based compensation (3,954)   (3,954)  
Share based compensation 1,187   1,187  
Net income (loss) 6,147     6,147
Ending balances (in shares) at Mar. 31, 2021   58,394,000    
Ending balances at Mar. 31, 2021 349,739 $ 58 346,176 3,505
Beginning balances (in shares) at Dec. 31, 2021   59,929,000    
Beginning balances at Dec. 31, 2021 $ 371,291 $ 60 361,087 10,144
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon exercise of options (in shares) 0      
Common stock issued in connection with business combinations (in shares)   650,000    
Common stock issued in connection with business combination $ 5,750 $ 1 5,749  
Common stock issued for share based compensation (in shares)   149,000    
Common stock issued for share based compensation 0      
Common stock withheld for employee payroll taxes (1,355)   (1,355)  
Share based compensation 1,583   1,583  
Net income (loss) (5,177)     (5,177)
Ending balances (in shares) at Mar. 31, 2022   60,728,000    
Ending balances at Mar. 31, 2022 $ 372,092 $ 61 $ 367,064 $ 4,967